β-Glucan polymer (β-glucan)

β-Glucan polymer is a heterogeneous class of naturally occurring polysaccharides composed of D-glucose monomers linked by β-glycosidic bonds, most commonly β-1,3 and/or β-1,4 linkages, and often possessing side branches of β-1,6 linkages[1][3][5]. β-Glucans are major structural components of the cell walls of fungi, yeast, bacteria, seaweeds, and cereals, and their physicochemical properties and biological activities depend on their source, linkage type, branching, and molecular weight[1][5]. Unlike canonical therapeutic targets (such as receptors or enzymes), β-glucan does not itself function as a receptor or enzyme but rather acts as a ligand—binding immune cell receptors (notably Dectin-1, complement receptor 3, and Toll-like receptor 2)[4][6]. This interaction initiates and modulates both innate and adaptive immune responses, leading to effects such as cytokine release, phagocytosis, B cell activation, and potential antitumor or anti-infective actions[4][6]. β-Glucans have been extensively studied as immunomodulators, and in some contexts are used as dietary supplements or adjuvants to support immune health, cholesterol lowering, or gut health, but are not themselves therapeutic "targets" in the sense of traditional drug development[2][5]. Summary of key point: "β-Glucan polymer" is not itself a *therapeutic target* (such as a receptor or enzyme) but a structural polysaccharide that binds to known immune cell receptors. It should not be catalogued as a drug target; rather, receptors *for* β-glucan such as Dectin-1 and Complement receptor 3 are the true druggable entities. Therefore, the entry is marked incorrect for "target" purposes.

Other names

beta-glucanβ-glucansbeta-1,3-glucanbeta-1,4-glucanmixed-linkage glucans